Skip to content
MarketScale
‹ Back to IndustriesHealthcare

CurveBeam Unveils New Logo

On the heels of a recent FDA approval for its LineUP system, CurveBeam unveiled a fresh, new look as it poises itself to enjoy a remarkable leadership position in the healthcare industry. CurveBeam unveiled a new logo design that it will transition to using in all branded content and materials. “CurveBeam’s primary focus is innovation,”…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

On the heels of a recent FDA approval for its LineUP system, CurveBeam unveiled a fresh, new look as it poises itself to enjoy a remarkable leadership position in the healthcare industry.

CurveBeam unveiled a new logo design that it will transition to using in all branded content and materials.

“CurveBeam’s primary focus is innovation,” explains Marketing Manager Vinti Singh. “Our new logo incorporates subtle design updates that reflect our culture of constant adaptation and change. However, the color scheme and swoop motif are preserved as a symbol of a commitment to our core values.”

With a line of cone beam scanning devices, CurveBeam allows clinics to offer weight bearing CT scanning to their patients to improve their quality of care. Here is the latest overview of the CurveBeam product line:

  • The InReach update this link is an extremity cone beam CT scanner that images the hand, wrist, forearm, elbow and the lower extremities. The InReach is the most compact orthopedic extremity CT scanner available.
  • The LineUP provides bilateral, weight-bearing CT imaging of the knee and lower extremities to redefine orthopedic care.
  • The pedCAT update this link is a compact, ultra-low dose CT imaging system that is ideal for orthopedic and podiatric clinics. Patients benefit from the convenience of point-of-care advanced diagnostic imaging. Scan time is one minute, and the pedCAT automatically generates all standard X-Ray views in addition to the full CT volume.
  • CubeVue software provides powerful visualization tools to enhance diagnosis. The pedCAT system comes complete with CubeVue installed. CubeVue automatically generates all standard X-Ray views, possibly eliminating the need for your plain X-Ray system altogether. Insta-X views are free from magnification, distortion or patient positioning inaccuracies.

CurveBeam has refreshed its brand and is committed to staying at the forefront of the orthopedic field as the healthcare industry evolves. As its team continues to push forward with new technology, CurveBeam is continuously evolving, always innovating, and keeping its approach to product development fresh.

CurveBeam was founded in 2009 by a group of individuals with a proven track record in the advanced and compact 3D imaging device domain. Learn more about the exciting things happening at CurveBeam today by our blog.

Read more at curvebeam.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

OpenAI’s ChatGPT for Healthcare is getting wired into Epic

OpenAI’s ChatGPT for Healthcare is getting wired into Epic

ChatGPT for Healthcare can now read from Epic. UCSF Health is piloting the read-only integration, according to Fierce Healthcare and Becker’s Hospital Review. For CIOs, the work is permissions, auditability, and clinical validation in Epic workflows.

  • 01The “read-only” label doesn’t remove governance work, it moves it to permissions mapping, audit logs, and connector scope design inside Epic-supported workflows.
  • 02OpenAI’s published clinician review results (99.1% rated safe across 4,363 ratings) are a useful benchmark, but they still need local validation on your own note templates, meds workflows, and specialty mix.

Sep 7, 2026

The EU’s MDR delay buys time, but it won’t clear your commissioning bottleneck

The European Commission backed extending EU MDR transition deadlines to December 2027 and December 2028, Medical Design & Outsourcing reported. It buys time, not ramp-up capacity. Design News cites digital commissioning and machine digital twins to cut “power-on” surprises and speed validation and operator training.

  • 01If an EU portfolio includes Class III, December 2027 is now the planning anchor, but the internal gating item may shift to validation capacity and automation readiness, not paperwork.
  • 02Digital commissioning is becoming a procurement spec, not a buzzword, because it lets teams run DFM/DFA learning loops before hardware is built, which Design News notes is meant to reduce machine power-on surprises.

Sep 5, 2026

HCA’s Q1 was not about volume. It was about coverage and collecting cash

HCA Healthcare reaffirmed 2026 guidance after Q1 weather and a muted respiratory season cut adjusted EBITDA by about $180 million, according to HealthLeaders and Fierce Healthcare. Payer mix shifted fast. Exchange admissions fell about 15% and uninsured admissions rose about 16%, Fierce reported.

  • 01A mild flu season can be a margin event: HCA tied a 42% drop in respiratory admissions to a roughly $180M adjusted EBITDA hit (HealthLeaders, Fierce Healthcare).
  • 02The 2026 risk is sliding from demand to coverage: HCA cited a $600M–$900M full-year EBITDA headwind from exchange-related changes, with $150M already in Q1 (HealthLeaders, Fierce Healthcare).
  • 03Supplemental payments are becoming an operating capability, not a windfall: HCA said Q1 Medicaid program net benefit was about $200M vs $80M expected (HealthLeaders, Fierce Healthcare), putting state-by-state reimbursement strategy on the CFO’s critical path.

Sep 5, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512